Company facts
- Headquarters
- San Carlos, California
- Most recent report
- 8-K, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1425205
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 71
News 8 of 254
Prospectuses and Registrations 8 of 88
- S-8 Registration statement for an employee plan Jun 18, 2026
- S-8 Registration statement for an employee plan Jun 18, 2026
- S-3ASR Automatic shelf registration Jun 18, 2026
- S-8 Registration statement for an employee plan Nov 12, 2025
- S-8 Registration statement for an employee plan Nov 12, 2025
- 424B5 Prospectus supplement for an offering Aug 22, 2025
- S-8 Registration statement for an employee plan Dec 13, 2024
- S-8 Registration statement for an employee plan Aug 9, 2024
Proxies 8 of 33
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material May 17, 2024
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
Ownership 8 of 452
- 4 Insider reported a trade Aug 12, 2026
- 4 Insider reported a trade Aug 10, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 28, 2026
- 4 Insider reported a trade Jun 18, 2026
- 4 Insider reported a trade Jun 18, 2026
- 4 Insider reported a trade Jun 18, 2026
- 4 Insider reported a trade Jun 18, 2026
Other 8 of 104
- ARS Annual report sent to shareholders May 1, 2026
- ARS Annual report sent to shareholders Apr 30, 2025
- ARS Annual report sent to shareholders May 1, 2024
- UPLOAD Comment letter from SEC staff Nov 21, 2023
- CORRESP Reply to SEC staff Nov 17, 2023
- UPLOAD Comment letter from SEC staff Oct 26, 2023
- ARS Annual report sent to shareholders Apr 27, 2023
- UPLOAD Comment letter from SEC staff Apr 25, 2023
Everything here comes from Iovance Biotherapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.